中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页 机构 成果 学者
  
  1. CAS IR Grid
机构
采集方式
内容类型
发表日期
学科主题
筛选

浏览/检索结果: 共4条，第1-4条 帮助

条数/页： 排序方式：
Serplulimab, a novel anti-PD-1 antibody, in patients with microsatellite instability-high solid tumours: an open-label, single-arm, multicentre, phase II trial 期刊论文  OAI收割
BRITISH JOURNAL OF CANCER, 2022
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
  |  收藏  |  浏览/下载：41/0  |  提交时间：2022/12/22
Nimotuzumab plus chemoradiotherapy versus placebo plus chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma (NPC): A prospective, randomized-controlled, double-blinded, multicenter phase III clinical trial. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Sun, Yan
  |  收藏  |  浏览/下载：39/0  |  提交时间：2022/12/23
D-0316 in patients with advanced T790M-positive EGFR-mutant non-small cell lung cancer who progressed on prior EGFR-TKI therapy: results from a phase II study (NCT03861156). 期刊论文  OAI收割
CANCER RESEARCH, 2021, 卷号: 81
作者:  Lu, Shun;  Zhang, Yiping;  Zhang, Guojun;  Zhou, Jianying;  Cang, Shundong
  |  收藏  |  浏览/下载：90/0  |  提交时间：2021/11/01
Efficacy and safety of HLX10, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors: A single-arm, multicenter, phase 2 study. 期刊论文  OAI收割
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Qin, Shukui;  Li, Jin;  Zhong, Haijun;  Jin, Chuan;  Chen, Lili
  |  收藏  |  浏览/下载：39/0  |  提交时间：2022/01/10